Excess Ticagrelor Mortality: Reporting Bias or a Canary in the Coal Mine? - 26/07/17
| Funding: No funding received. |
|
| Conflict of Interest: OH is a former employee of AstraZeneca and owns stock in AstraZeneca. From 2005 to 2011, OH was a member of the global ticagrelor product team with responsibility for the Health Economics and Outcome Research aspects of the ticagrelor development program. OH is the owner/operator of Hauch Consultancy, Rue De Bordeaux 54, St. Gilles, Belgium. Hauch Consultancy does not have AstraZeneca as a client and OH has not worked for AstraZeneca since he left AstraZeneca in December of 2015. |
|
| Authorship: The author is solely responsible for writing this manuscript. |
Vol 130 - N° 8
P. e351 - août 2017 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
